Iterum Therapeutics PLC (NASDAQ:ITRM) reported its fourth-quarter 2024 financial results, revealing a narrower-than-expected loss. The company posted an actual EPS of -0.12, beating the forecasted EPS ...

While its ad segment’s rate of growth cooled in Q4 compared to the year-ago period, Amazon has successfully won over more non ...

Kimco Realty (NYSE:KIM) delivered in-line Q4 earnings and introduced 2025 FFO guidance midpoint that matches the average analyst estimate Q4 revenue, though, beat the Wall Street consensus, as rents ...

Most Wall Street equity researchers still believe that AVGO stock has room to grow, despite shifting circumstances in the ...